Posts Tagged ‘security-page-CBP’
Prescription drug freight fraud report, January 2026
The last two months of 2025 saw thousands of shipments of drugs popularized by social media imported into the U.S., as well as Xarelto and antibiotics. The shipments carried a wide range of product codes; some appropriate, and others far less so.
[...]Prescription Drug Freight Fraud Report, November 2025
Our analysis of data in September and October 2025 revealed that large-scale freight fraud involving GLP-1s, oncology drugs, and other high-demand pharmaceuticals continues unabated.
[...]Prescription Drug Freight Fraud Report, October 2025
What large-scale commercial imports made it into the country between March and August of 2025?
[...]Prescription Drug Freight Fraud Report, September 2025
Our analysis of data from June and July revealed hundreds of pharmaceutical shipments that entered the U.S. from facilities no one would expect, including unregistered Chinese exporters and alternative medicine clinics abroad.
[...]PSM leads letter in support of an FDA mandate to destroy high-risk imports
PSM led a coalition of organizations urging leaders of the Senate HELP and House Energy and Commerce committees to help strengthen the FDA’s ability to protect Americans from unsafe and counterfeit medicines and medical products.
[...]Prescription Drug Freight Fraud Report, July 2025
What if your tirzepatide shipment came from a Brazilian beauty clinic? Or a vial of semaglutide was manufactured, supposedly, at a Costco in Toronto? In April and May 2025, dozens of shipments of semaglutide, tirzepatide, apixaban, and antibiotics entered the U.S. from facilities that aren’t in the FDA’s drug manufacturing database. These aren’t low-volume personal-use…
[...]Prescription Drug Freight Fraud Report, May 2025
What if your blood thinners were made in an unverified location in Colombia? In March 2025, dozens of pharmaceutical shipments entered the U.S. that were manufactured in places no one would expect.
[...]PSM submits comment on CBP’s proposed rules to improve screening of low-value shipments
On March 14, the Partnership for Safe Medicines submitted comment on Customs and Border Protection’s proposed update to regulations around low-value, “de minimus” shipments.
[...]Newly Launched Federal Task Force Finds Fake Xanax and Botox in First Week of Operation at Michigan Ports of Entry
The Detroit branch of the newly launched Global Trade Task Force (GTTF) has found counterfeit medications amongst the $1 million worth of counterfeit goods seized during one week. The seizures occurred at the Detroit Metro Airport, and the Port Huron Blue Water Bridge ports of entry.
[...]Keeping The Drug Supply Chain Safe Keeps Patients Safe
In a statement from the U.S. Food and Drug Administration, Commissioner Scott Gottlieb, M.D. discussed the agency’s continuing efforts to combat the spread of illicit opioids and to ensure the security of America’s drug supply chain. Included in their recent efforts, Commissioner Gottlieb noted that the agency has stepped up enforcement and interdiction work at International Mail Facilities and shut down websites illegally selling potentially dangerous, unapproved, and misbranded versions of opioid medications to U.S. citizens…
[...]